Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
53 participants
OBSERVATIONAL
2018-09-30
2022-10-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Methamphetamine on Residual Latent HIV Disease Study
NCT03825536
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
NCT00789009
Evaluation and Monitoring of Patients With HIV Infectionn
NCT00557570
Analysis of HIV-1 Replication During Antiretroviral Therapy
NCT00767312
Treatment of Acute HIV Infection to Preserve Immune Function
NCT00055094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Leukocyte DNA Samples
Leukocyte DNA specimens extracted from participants enrolled in a completed NIH funded trial will be examined to determine if prior exposure to different behavioral interventions modifies DNA methylation patterns over 6 months.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documentation of HIV-positive serostatus
* Speak English
* Biological verification of recent methamphetamine use
* Completion of at least three contingency management (CM) visits
* Self reported anal sex with a man in the past 12 months
Exclusion Criteria
* HIV negative serostatus
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York University
OTHER
Northwestern University
OTHER
University of California, San Francisco
OTHER
National Institute on Drug Abuse (NIDA)
NIH
Florida International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adam Carrico, PhD
Professor and Chair
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam W Carrico, PhD
Role: PRINCIPAL_INVESTIGATOR
Florida International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Florida International University
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20180865
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.